Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03094221 · ClinicalTrials.gov registry record
Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias
A clinical trial of Cardiac Arrhythmias and Electroanatomic Mapping, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT03094221 is a study of Cardiac Arrhythmias and Electroanatomic Mapping that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 20 participants, below the 538-participant average among 5 other Cardiac Arrhythmias trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03094221, a study of Cardiac Arrhythmias and Electroanatomic Mapping, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare two different types of three-dimensional electroanatomic mapping systems used for the treatment of cardiac arrhythmias. The systems will be compared in regards to its ability to successfully map and ablate a clinical arrhythmia, as well as the time invested in this activity.
Conditions Studied
Interventions
- DEVICE Rhythmia Mapping System
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-01-13 |
| Est. Completion | 2015-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03094221
The ClinicalTrials.gov registry entry for NCT03094221 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 538-participant average among 5 other Cardiac Arrhythmias trials with a reported enrollment target (96% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cardiac Arrhythmias appearing as the primary indexed condition, and to 1 intervention - of which Rhythmia Mapping System is the first listed.
NCT03094221 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03094221 about?
NCT03094221 is a clinical study titled "Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias". The purpose of this study is to compare two different types of three-dimensional electroanatomic mapping systems used for the treatment of cardiac arrhythmias. The systems will be compared in regards to its ability to successfully map and ablate a clinical arrhythmia, as well as the time invested in...
What is the current status of trial NCT03094221?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2015-01-13. Estimated completion is 2015-12-01.
What conditions does trial NCT03094221 study?
This clinical trial studies the following conditions: Cardiac Arrhythmias, Electroanatomic Mapping, Cardiac Ablation.
What interventions are being tested in trial NCT03094221?
The interventions under investigation include: Rhythmia Mapping System (DEVICE).
Who is sponsoring clinical trial NCT03094221?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03094221 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrhythmias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
RECRUITING
-
ViewFlex X ICE First-in-Human Study
RECRUITING
-
EluPro Antibiotic-Eluting BioEnvelope Registry
RECRUITING
-
Confirm Rx Insertable Cardiac Monitor SMART Registry
ACTIVE NOT RECRUITING
-
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
COMPLETED
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.